Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
ENDRA Life Sciences Inc. (NDRA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/01/2023 |
4
| Basenese Lou (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 6,746 options
@ $4.02, valued at
$27.1k
|
|
| 02/01/2023 |
4
| Tokman Alexander Y (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 9,621 options
@ $4.02, valued at
$38.7k
|
|
| 02/01/2023 |
4
| Harsh Michael (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 9,634 options
@ $4.02, valued at
$38.7k
|
|
| 02/01/2023 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 9,621 options
@ $4.02, valued at
$38.7k
|
|
| 02/01/2023 |
4
| Pestrikova Irina (Senior Director, Finance) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 8,000 options
@ $4.02, valued at
$32.2k
|
|
| 02/01/2023 |
4
| Thornton Michael Milos (Chief Technology Officer) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 68,066 options
@ $4.02, valued at
$273.6k
|
|
| 02/01/2023 |
4
| Michelon Francois Roger (CEO) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 69,531 options
@ $4.02, valued at
$279.5k
|
|
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2022 |
4
| Thornton Michael Milos (Chief Technology Officer) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Bought 20,000 shares
@ $0.27, valued at
$5.4k
|
|
| 08/24/2022 |
4
| Tokman Alexander Y (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Bought 20,000 shares
@ $0.26, valued at
$5.2k
|
|
| 05/31/2022 |
4
| Thornton Michael Milos (Chief Technology Officer) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Bought 25,000 shares
@ $0.21, valued at
$5.3k
|
|
| 05/23/2022 |
4
| Thornton Michael Milos (Chief Technology Officer) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Bought 25,000 shares
@ $0.22, valued at
$5.5k
|
|
| 05/19/2022 |
4
| Michelon Francois Roger (CEO) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Bought 5,100 shares
@ $0.19, valued at
$969 |
|
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/30/2022 |
4
| Maloberti Renaud Bertrand (Chief Commercial Officer) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 186,430 options
@ $0.38, valued at
$70.8k
|
|
| 03/30/2022 |
4
| Thornton Michael Milos (Chief Technology Officer) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 698,102 options
@ $0.38, valued at
$265.3k
|
|
| 03/30/2022 |
4
| Michelon Francois Roger (CEO) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 713,132 options
@ $0.38, valued at
$271k
|
|
| 03/30/2022 |
4
| Tokman Alexander Y (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 109,323 options
@ $0.38, valued at
$41.5k
|
|
| 03/30/2022 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 109,323 options
@ $0.38, valued at
$41.5k
|
|
| 03/30/2022 |
4
| Pestrikova Irina (Senior Director, Finance) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 41,500 options
@ $0.38, valued at
$15.8k
|
|
| 03/30/2022 |
4
| Harsh Michael (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 109,492 options
@ $0.38, valued at
$41.6k
|
|
| 03/30/2022 |
4
| Basenese Lou (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 74,500 options
@ $0.38, valued at
$28.3k
|
|
| 01/04/2022 |
4
| Tokman Alexander Y (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 12,000 options
@ $0.74, valued at
$8.9k
|
|
| 01/04/2022 |
4
| DIGIANDOMENICO ANTHONY (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 12,000 options
@ $0.74, valued at
$8.9k
|
|
| 01/04/2022 |
4
| Harsh Michael (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 12,000 options
@ $0.74, valued at
$8.9k
|
|
| 01/04/2022 |
4
| Basenese Lou (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 12,000 options
@ $0.74, valued at
$8.9k
|
|
| 09/22/2021 |
4
| Thornton Michael Milos (Chief Technology Officer) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 22,815 shares
@ $0 |
|
| 08/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| Pestrikova Irina (Senior Director, Finance) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 75,000 options
@ $2.11, valued at
$158.3k
|
|
| 04/30/2021 |
4
| Thornton Michael Milos (Chief Technology Officer) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 22,815 shares
@ $0 |
|
| 04/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2021 |
4
| Harsh Michael (Director) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 25,000 options
@ $2.64, valued at
$66k
|
|
| 04/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|